Remodulin, treprostinil (MD-0701)

Also known as: formerly Uniprost, UT-15

General Information

Company	United Therapeutics Corp.
Description	Synthetic long-acting stable prostacyclin analog
Molecular Target	Not available
Mechanism of Action	Unknown

Latest Stage of Development	Marketed
Indication	Hypertension
Partner	Bioprojet Pharma S.a.r.l.; Mochida Pharmaceutical Co. Ltd.

Product Details

Archive Items are loading